£129.15

Springer New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Price data last checked 8 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£129 today · all-time low £129 (Mar 2026) · usually £129

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 83 days • 83 data points (No recent data available)

Historical
Generating forecast...
£129.21 £129.09 £129.12 £129.14 £129.17 £129.19 £129.22 24 March 2026 13 April 2026 04 May 2026 24 May 2026 14 June 2026

Price Distribution

Price distribution over 83 days • 1 price levels

Days at Price
83 days 0 21 42 62 83 £129 Days at Price

Price Analysis

Most common price: £129 (83 days, 100.0%)

Price range: £129 - £129

Price levels: 1 different prices over 83 days

Description

The decade of the 1990s will see an increasing emphasis on the modulation of chemotherapeutic drug selectivity and in the 'lock and key' approach to new targets to control malignant proliferation. The contents of this volume appropriately reflect these scientific undercurrents. An emerging powerful tool of molecular pharmacology is described by Holcenberg and Wu. Manipulation of genetic expression by modification of messenger RNA is now within our reach, and the basic concepts are suc cinctly reviewed as a primer on future biochemical engineering of new anti cancer molecules. Another concept that appears to be worthy of further study in both experimental and clinical chemotherapy concerns obs'ervations on the modulation of activity by the nucleoside transport inhibitor, dipyri damole. How potentiation of several anticancer drugs occurs has practical, as well as theoretical, ramifications, discussed by Goel and HowelL Finally, O'Dwyer and La Creta present a fresh look at sensitization of chemotherapy by the hypoxic radiosensitizer, SR-2731.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 October 1991
Listed Since
15 February 2007

Barcode

No barcode data available

Similar Products You Might Like

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
84% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 31 May 2026
Pharmaceutical Perspectives of Cancer Therapeutics
83% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 06 Jun 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
83% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 25 May 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
83% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 05 Jun 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
82% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£163.85 31 May 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
82% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.98 29 May 2026
Molecular Targeted Therapy of Lung Cancer
82% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.70 06 Jun 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
82% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£77.83 31 May 2026
Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)
81% match

Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)

Springer

£109.06 03 Jun 2026
New Trends in Cancer for the 21st Century: 587 (Advances in Experimental Medicine and Biology, 587)
81% match

New Trends in Cancer for the 21st Century: 587 (Advances in Experimental Medicine and Biology, 587)

Springer

£147.11 23 May 2026
The Histone Code and Beyond: New Approaches to Cancer Therapy: 57 (Ernst Schering Foundation Symposium Proceedings, 57)
81% match

The Histone Code and Beyond: New Approaches to Cancer Therapy: 57 (Ernst Schering Foundation Symposium Proceedings, 57)

Springer

£76.38 01 Jun 2026
Cancer II: 28 (Topics in Medicinal Chemistry, 28)
81% match

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Springer

£199.19 20 May 2026
DNA Topoisomerases in Cancer Therapy: Present and Future
80% match

DNA Topoisomerases in Cancer Therapy: Present and Future

Springer

£82.26 01 Jun 2026
Cancer Drug Discovery: Science and History
80% match

Cancer Drug Discovery: Science and History

Springer

£109.19 24 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
80% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 26 May 2026
80% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£153.99 22 May 2026
Gene Regulation and Therapeutics for Cancer
80% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£69.94 20 May 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
80% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 25 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
80% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
Nutraceuticals and Cancer
80% match

Nutraceuticals and Cancer

Springer

£113.76 25 May 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
80% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£130.93 20 May 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
80% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£107.98 06 Jun 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
80% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£107.98 24 May 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
80% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Academic Press

£157.99 23 May 2026